.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Medtronic
Cipla
Merck
McKesson
Express Scripts
Accenture
Cerilliant
Argus Health
Boehringer Ingelheim

Generated: December 15, 2017

DrugPatentWatch Database Preview

BLEPH-10 Drug Profile

« Back to Dashboard

When do Bleph-10 patents expire, and when can generic versions of Bleph-10 launch?

Bleph-10 is a drug marketed by Allergan and is included in two NDAs.

The generic ingredient in BLEPH-10 is sulfacetamide sodium. There are three drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
Drug patent expirations by year for BLEPH-10

Pharmacology for BLEPH-10

Ingredient-typeSulfonamides
Drug ClassSulfonamide Antibacterial

Medical Subject Heading (MeSH) Categories for BLEPH-10

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
AllerganBLEPH-10sulfacetamide sodiumOINTMENT;OPHTHALMIC084015-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
AllerganBLEPH-10sulfacetamide sodiumSOLUTION/DROPS;OPHTHALMIC080028-001Approved Prior to Jan 1, 1982ATRXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Dow
McKinsey
Cipla
US Department of Justice
Citi
Harvard Business School
Mallinckrodt
Chubb
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot